ADHD Frequently Co-Occurs with Autism Spectrum Disorder

Share this content:
ADHD Frequently Co-Occurs with Autism Spectrum Disorder
ADHD Frequently Co-Occurs with Autism Spectrum Disorder

THURSDAY, April 5, 2018 (HealthDay News) -- Co-occurrence of attention-deficit/hyperactivity disorder (ADHD) is common in children with autism spectrum disorder (ASD), and children with both conditions have a higher risk of anxiety and mood disorders, according to a study published in the April issue of Pediatrics.

In an effort to compare the comorbidity of anxiety and mood disorders in children with ASD, with and without ADHD, Eliza Gordon-Lipkin, M.D., from the Kennedy Krieger Institute in Baltimore, and colleagues used child data (aged 6 to 17 years) from the Interactive Autism Network, an internet-mediated, parent-report, autism research registry.

The researchers found that 45.3 percent of the 3,319 children included in the analysis had ADHD. Comorbid ADHD increased with age (P < 0.001) and was associated with increased ASD severity (P < 0.001). Compared with children with ASD alone, children with ASD and ADHD had an increased risk of anxiety disorder (adjusted relative risk, 2.20) and mood disorder (adjusted relative risk, 2.72).

"Co-occurrence of ADHD is common in children with ASD. Children with both ASD and ADHD have an increased risk of anxiety and mood disorders," the authors write. "Physicians who care for children with ASD should be aware of the coexistence of these treatable conditions."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »